
Novozymes A/S
CSE:NZYM B

Novozymes A/S?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Novozymes A/S hold over its rivals?
What risks and challenges
does Novozymes A/S face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Novozymes A/S.
Provide an overview of the primary business activities
of Novozymes A/S.
What unique competitive advantages
does Novozymes A/S hold over its rivals?
What risks and challenges
does Novozymes A/S face in the near future?
Summarize the latest earnings call
of Novozymes A/S.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Novozymes A/S.
Provide P/S
for Novozymes A/S.
Provide P/E
for Novozymes A/S.
Provide P/OCF
for Novozymes A/S.
Provide P/FCFE
for Novozymes A/S.
Provide P/B
for Novozymes A/S.
Provide EV/S
for Novozymes A/S.
Provide EV/GP
for Novozymes A/S.
Provide EV/EBITDA
for Novozymes A/S.
Provide EV/EBIT
for Novozymes A/S.
Provide EV/OCF
for Novozymes A/S.
Provide EV/FCFF
for Novozymes A/S.
Provide EV/IC
for Novozymes A/S.
Show me price targets
for Novozymes A/S made by professional analysts.
What are the Revenue projections
for Novozymes A/S?
How accurate were the past Revenue estimates
for Novozymes A/S?
What are the Net Income projections
for Novozymes A/S?
How accurate were the past Net Income estimates
for Novozymes A/S?
What are the EPS projections
for Novozymes A/S?
How accurate were the past EPS estimates
for Novozymes A/S?
What are the EBIT projections
for Novozymes A/S?
How accurate were the past EBIT estimates
for Novozymes A/S?
Compare the revenue forecasts
for Novozymes A/S with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Novozymes A/S and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Novozymes A/S against its competitors.
Analyze the profit margins
(gross, operating, and net) of Novozymes A/S compared to its peers.
Compare the P/E ratios
of Novozymes A/S against its peers.
Discuss the investment returns and shareholder value creation
comparing Novozymes A/S with its peers.
Analyze the financial leverage
of Novozymes A/S compared to its main competitors.
Show all profitability ratios
for Novozymes A/S.
Provide ROE
for Novozymes A/S.
Provide ROA
for Novozymes A/S.
Provide ROIC
for Novozymes A/S.
Provide ROCE
for Novozymes A/S.
Provide Gross Margin
for Novozymes A/S.
Provide Operating Margin
for Novozymes A/S.
Provide Net Margin
for Novozymes A/S.
Provide FCF Margin
for Novozymes A/S.
Show all solvency ratios
for Novozymes A/S.
Provide D/E Ratio
for Novozymes A/S.
Provide D/A Ratio
for Novozymes A/S.
Provide Interest Coverage Ratio
for Novozymes A/S.
Provide Altman Z-Score Ratio
for Novozymes A/S.
Provide Quick Ratio
for Novozymes A/S.
Provide Current Ratio
for Novozymes A/S.
Provide Cash Ratio
for Novozymes A/S.
What is the historical Revenue growth
over the last 5 years for Novozymes A/S?
What is the historical Net Income growth
over the last 5 years for Novozymes A/S?
What is the current Free Cash Flow
of Novozymes A/S?
Discuss the annual earnings per share (EPS)
trend over the past five years for Novozymes A/S.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
DK |
![]() |
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 28.9 | |
US |
![]() |
Sherwin-Williams Co
NYSE:SHW
|
83.6B USD | 21 |
|
US |
![]() |
Ecolab Inc
NYSE:ECL
|
74.1B USD | 22.2 |
|
JP |
![]() |
Shin-Etsu Chemical Co Ltd
TSE:4063
|
8.6T JPY | 7 |
|
CH |
![]() |
Givaudan SA
SIX:GIVN
|
36.9B CHF | 22.7 |
|
CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
24.9B EUR | 13.4 |
|
US |
![]() |
Dupont De Nemours Inc
NYSE:DD
|
27.7B USD | 9.3 |
|
IN |
![]() |
Asian Paints Ltd
NSE:ASIANPAINT
|
2.2T INR | 35.9 |
|
US |
![]() |
PPG Industries Inc
NYSE:PPG
|
24.7B USD | 12.4 |
|
CN |
![]() |
Wanhua Chemical Group Co Ltd
SSE:600309
|
167B CNY | 15.7 |
|
CH |
![]() |
Sika AG
F:SIKA
|
19.9B EUR | 10.3 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
DK |
![]() |
Novozymes A/S
CSE:NZYM B
|
Average EV/EBITDA:
18.1
28.9
|
N/A | N/A | |
US |
![]() |
Sherwin-Williams Co
NYSE:SHW
|
21
|
9%
|
2.3 |
|
US |
![]() |
Ecolab Inc
NYSE:ECL
|
22.2
|
9%
|
2.5 |
|
JP |
![]() |
Shin-Etsu Chemical Co Ltd
TSE:4063
|
7
|
6%
|
1.2 |
|
CH |
![]() |
Givaudan SA
SIX:GIVN
|
22.7
|
6%
|
3.8 |
|
CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
13.4
|
11%
|
1.2 |
|
US |
![]() |
Dupont De Nemours Inc
NYSE:DD
|
9.3
|
8%
|
1.2 |
|
IN |
![]() |
Asian Paints Ltd
NSE:ASIANPAINT
|
35.9
|
10%
|
3.6 |
|
US |
![]() |
PPG Industries Inc
NYSE:PPG
|
12.4
|
5%
|
2.5 |
|
CN |
![]() |
Wanhua Chemical Group Co Ltd
SSE:600309
|
15.7
|
31%
|
0.5 |
|
CH |
![]() |
Sika AG
F:SIKA
|
10.3
|
7%
|
1.5 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.